1,4-DIHYDRO-1,6-NAPHTHYRIDIN-4-ONE, 95.0%, 250mg

3'-chloro-3-(4-thiomethylphenyl)propiophenone, 97.0%, 1g

(S)-5-Oxopiperazine-2-carboxylic acid hydrochloride, 95.0%, 1g

Potassium Butylxanthate>95.0%(T)25g

4-Bromo-2-ethylaniline, 95.0%, 1g

(3R,4R)-(-)-1-Benzyl-3,4-pyrrolidinediol, 97.0%, 5g

1-(2-hydroxyethyl)-5-propyl-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

1-ACETYLINDOLE, 97.0%, 250mg

o-ftaldialdehído, mínimo 98 %, para síntesis, 25 g, envase de vidrio

4-Bromo-1-methyl-1H-pyrazolo[4,3-c]pyridine-6-carboxylic acid, 98%, 250mg

(5-Methoxypyridin-3-yl)methanamine dihydrochloride, 97%, 100mg

1-[[1,1'-Biphenyl]-2-yl]ethan-1-one>98.0%(GC)1g

2-Oxo-1-(propan-2-yl)-1,2-dihydropyridine-3-carboxylic acid, 250mg